<DOC>
	<DOCNO>NCT00328029</DOCNO>
	<brief_summary>Recently , several conditioning regimen include total body irradiation ( TBI ) anymore , especially case young child due cognitive sequela late effect growth height . Thus , effective chemotherapy conditioning regimen develop avoid complication . Busulfan one major drug use treatment , , also administer high dose chemotherapy follow autograft . In situation , long term pulmonary side effect diagnose case . Even occurrence frequent , clinical management real challenge regard reduce quality life life expectancy patient . Up , correlation do respiratory sequela busulfan pharmacokinetics . Hence , investigator ' pediatric onco-hematological unit , prospective study begin last three year assess respiratory side effect due busulfan potential link individual drug pharmacokinetic measure . These result compare patient treat TBI period time .</brief_summary>
	<brief_title>Respiratory Side Effects Busulfan High Dose Chemotherapy Pediatric Population</brief_title>
	<detailed_description />
	<mesh_term>Signs Symptoms</mesh_term>
	<mesh_term>Signs Symptoms , Respiratory</mesh_term>
	<mesh_term>Busulfan</mesh_term>
	<criteria>Patients 3 year old treat busulfan TBI conditioning regimen allograft busulfan high dose chemotherapeutic regimen follow autograft include parent inform assent .</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Busulfan</keyword>
	<keyword>pharmacokinetic</keyword>
	<keyword>respiratory function assessment</keyword>
	<keyword>Busulfan pharmacokinetic respiratory function test</keyword>
</DOC>